Our Medicines

Two figures in white coats looking at laboratory equipment, viewed through a glass window which has chemical formulae written on it
style
background-none
medicine capsule icon

For more than 150 years, we have focused on research and development to bring medicines to patients.

The product information on this website is intended for UK residents over the age of eighteen years only.
style
background-primary-red
additionalPadding
narrow
style
background-none

Current Medicines

style
background-none, three-col-33-33-33
extra-styles
offset

Abasaglar®

Insulin glargine

Adcirca®

Tadalafil*

Alimta®

Pemetrexed
style
background-none, three-col-33-33-33
extra-styles
offset
style
background-none

Baricitinib Lilly

Cialis®

Tadalafil
Cyramza®
Ramucirumab
style
background-none, three-col-33-33-33
extra-styles
offset

Emgality®

Galcanezumab*

Forsteo®

Teriparatide
Humalog®
Insulin lispro
style
background-none, three-col-33-33-33
extra-styles
offset
style
background-none
Humulin®
Human insulin
Jaypirca®▼
Pirtobrutinib

Kisunla®▼

Donanemab
style
background-none, three-col-33-33-33
extra-styles
offset
style
background-none
Lyumjev®
Insulin lispro
Mounjaro®▼
Tirzepatide

Omvoh®▼

Mirikizumab
style
background-none, three-col-33-33-33
extra-styles
offset
style
background-none
Retsevmo®▼
Selpercatinib
Taltz®
Ixekizumab
Trulicity®
Dulaglutide
style
background-none, three-col-33-33-33
extra-styles
offset
style
background-none
Verzenios®
Abemaciclib
style
background-none, three-col-33-33-33
extra-styles
offset
*Lilly is the marketing authorisation holder (MAH) but does not promote this product.
style
background-none

Information Resources

To view summaries of product characteristics (SmPC), patient information leaflets (PIL), and instructions for use (IFU), please visit the Electronic Medicines Compendium website.
true
Scientist working in a lab
View more
style
background-none

Devices -
Instructions for Use

additional-link, ctaselection-link, ctatarget-newtab, ctaexitinterstitial-downloadable-item
HumaPen Savvio® instructions for use
style
background-none, two-col-50-50
extra-styles
offset
man looking at a mobile phone
style
background-none
additionalPadding
narrow

Report an Adverse Event,
Product Complaint
or Suspected
Counterfeit Product

If you experience side effects taking a Lilly medicine, talk to your doctor or other healthcare professional. This includes any possible side effects not listed in the package leaflet. By reporting side effects, you can help provide information on the safety of medicines. See the Yellow Card website or search for MHRA Yellow Card in the Google Play or Apple App Store for how to report side effects.

You can also report a side effect, product complaint or suspected counterfeit Lilly product directly to Lilly UK using the contact details below.

Medicines with the black triangle symbol (▼) have additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the Yellow Card website or search for MHRA Yellow Card in the Google Play or Apple App Store for how to report side effects.
style
background-none, two-col-50-50
extra-styles
offset
style
background-none

Contact us

To make a report to Lilly UK, you can call us on 01256 315000 or email us at
UKMedInfo@Lilly.com
style
background-primary-red
additionalPadding
narrow
additionalMargin
narrow
roundedBorders
true
CMAT-06478 June 2026
style
background-none